These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22962420)

  • 1. Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy.
    Miranda RI; Nault M; Johri A; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):927-32. PubMed ID: 22962420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing.
    Miranda RI; Nault M; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):370-4. PubMed ID: 22049976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on right ventricular outflow tract septal pacing.
    Da Costa A; Gabriel L; Romeyer-Bouchard C; Géraldine B; Gate-Martinet A; Laurence B; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(6-7):394-403. PubMed ID: 23850059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter by Filgueiras-Rama et al regarding article, "Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy" by Miranda et al.
    Filgueiras-Rama D; Garofalo D; Gómez-Gallanti A
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):e24. PubMed ID: 23592876
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
    Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC;
    J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of right and left ventricular lead positions during the implantation of cardiac resynchronization therapy defibrillators.
    Stockinger J; Staier K; Schiebeling-Römer J; Keyl C
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1537-43. PubMed ID: 21797906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of two surgical alternatives for cardiac resynchronization therapy: trans-apical versus epicardial left ventricular pacing.
    Mihalcz A; Kassai I; Kardos A; Foldesi C; Theuns D; Szili-Torok T
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):124-30. PubMed ID: 22017475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of defibrillator lead implantations in the right ventricular mid-septum versus the apex: the SEPTAL study.
    Mabo P; Defaye P; Mouton E; Cebron JP; Davy JM; Tassin A; Babuty D; Mondoly P; Paziaud O; Anselme F; Daubert JC
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):853-60. PubMed ID: 22452288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial).
    Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
    Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops.
    Dekker AL; Phelps B; Dijkman B; van der Nagel T; van der Veen FH; Geskes GG; Maessen JG
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1641-7. PubMed ID: 15173718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.